Stella Pharma Corporation 4888.T Stock
Stella Pharma Corporation Price Chart
Stella Pharma Corporation 4888.T Financial and Trading Overview
| Stella Pharma Corporation stock price | 278 JPY |
| Previous Close | 324 JPY |
| Open | 321 JPY |
| Bid | 326 JPY x N/A |
| Ask | 328 JPY x N/A |
| Day's Range | 321 - 329 JPY |
| 52 Week Range | 311 - 624 JPY |
| Volume | 94.3K JPY |
| Avg. Volume | 184.49K JPY |
| Market Cap | 9.41B JPY |
| Beta (5Y Monthly) | 1.271112 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -25.31 JPY |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
4888.T Valuation Measures
| Enterprise Value | 7.93B JPY |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 41.07319 |
| Price/Book (mrq) | 3.5136583 |
| Enterprise Value/Revenue | 34.649 |
| Enterprise Value/EBITDA | -10.291 |
Trading Information
Stella Pharma Corporation Stock Price History
| Beta (5Y Monthly) | 1.271112 |
| 52-Week Change | -0.30% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 624 JPY |
| 52 Week Low | 311 JPY |
| 50-Day Moving Average | 355.22 JPY |
| 200-Day Moving Average | 396.42 JPY |
4888.T Share Statistics
| Avg. Volume (3 month) | 184.49K JPY |
| Avg. Daily Volume (10-Days) | 174.09K JPY |
| Shares Outstanding | 28.68M |
| Float | 16.59M |
| Short Ratio | N/A |
| % Held by Insiders | 53.49% |
| % Held by Institutions | 11.61% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | March 31, 2023 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | March 31, 2024 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -351.96% |
| Gross Margin | 90.39% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -11.13% |
| Return on Equity (ttm) | -26.68% |
Income Statement
| Revenue (ttm) | 229M JPY |
| Revenue Per Share (ttm) | 7.93 JPY |
| Quarterly Revenue Growth (yoy) | 237.50% |
| Gross Profit (ttm) | N/A |
| EBITDA | -771000000 JPY |
| Net Income Avi to Common (ttm) | -778000000 JPY |
| Diluted EPS (ttm) | -23.68 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 2.71B JPY |
| Total Cash Per Share (mrq) | 91.93 JPY |
| Total Debt (mrq) | 1.09B JPY |
| Total Debt/Equity (mrq) | 39.72 JPY |
| Current Ratio (mrq) | 9.007 |
| Book Value Per Share (mrq) | 93.35 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -827000000 JPY |
| Levered Free Cash Flow (ttm) | -569000000 JPY |
Profile of Stella Pharma Corporation
| Country | Japan |
| State | N/A |
| City | Osaka |
| Address | ORIX Kouraibashi Building |
| ZIP | 541-0043 |
| Phone | 81 6 4707 1516 |
| Website | https://www.stella-pharma.co.jp |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Stella Pharma Corporation engages in the research, development, manufacturing, and distribution of pharmaceuticals. The company develops drugs for boron neutron capture therapy (BNCT). Its product includes SPM-011, a boron-containing drug for BNCT for treating head and neck cancer, recurrent malignant glioma and meningioma, and malignant melanoma and angiosarcoma. The company was founded in 2007 and is headquartered in Osaka, Japan.
Q&A For Stella Pharma Corporation Stock
What is a current 4888.T stock price?
Stella Pharma Corporation 4888.T stock price today per share is 278 JPY.
How to purchase Stella Pharma Corporation stock?
You can buy 4888.T shares on the Tokyo exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Stella Pharma Corporation?
The stock symbol or ticker of Stella Pharma Corporation is 4888.T.
Which industry does the Stella Pharma Corporation company belong to?
The Stella Pharma Corporation industry is Biotechnology.
How many shares does Stella Pharma Corporation have in circulation?
The max supply of Stella Pharma Corporation shares is 31.23M.
What is Stella Pharma Corporation Price to Earnings Ratio (PE Ratio)?
Stella Pharma Corporation PE Ratio is now.
What was Stella Pharma Corporation earnings per share over the trailing 12 months (TTM)?
Stella Pharma Corporation EPS is -25.31 JPY over the trailing 12 months.
Which sector does the Stella Pharma Corporation company belong to?
The Stella Pharma Corporation sector is Healthcare.